Cargando…

A rapid decline in the anti–receptor-binding domain of the SARS-CoV-2 spike protein IgG titer in kidney transplant recipients after tixagevimab–cilgavimab administration

Detalles Bibliográficos
Autores principales: Benotmane, Ilies, Velay, Aurélie, Vargas, Gabriela-Gautier, Olagne, Jérôme, Cognard, Noëlle, Heibel, Françoise, Braun-Parvez, Laura, Martzloff, Jonas, Perrin, Peggy, Pszczolinski, Romain, Moulin, Bruno, Fafi-Kremer, Samira, Caillard, Sophie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society of Nephrology. Published by Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375643/
https://www.ncbi.nlm.nih.gov/pubmed/35973595
http://dx.doi.org/10.1016/j.kint.2022.07.022
_version_ 1784768010326638592
author Benotmane, Ilies
Velay, Aurélie
Vargas, Gabriela-Gautier
Olagne, Jérôme
Cognard, Noëlle
Heibel, Françoise
Braun-Parvez, Laura
Martzloff, Jonas
Perrin, Peggy
Pszczolinski, Romain
Moulin, Bruno
Fafi-Kremer, Samira
Caillard, Sophie
author_facet Benotmane, Ilies
Velay, Aurélie
Vargas, Gabriela-Gautier
Olagne, Jérôme
Cognard, Noëlle
Heibel, Françoise
Braun-Parvez, Laura
Martzloff, Jonas
Perrin, Peggy
Pszczolinski, Romain
Moulin, Bruno
Fafi-Kremer, Samira
Caillard, Sophie
author_sort Benotmane, Ilies
collection PubMed
description
format Online
Article
Text
id pubmed-9375643
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher International Society of Nephrology. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-93756432022-08-15 A rapid decline in the anti–receptor-binding domain of the SARS-CoV-2 spike protein IgG titer in kidney transplant recipients after tixagevimab–cilgavimab administration Benotmane, Ilies Velay, Aurélie Vargas, Gabriela-Gautier Olagne, Jérôme Cognard, Noëlle Heibel, Françoise Braun-Parvez, Laura Martzloff, Jonas Perrin, Peggy Pszczolinski, Romain Moulin, Bruno Fafi-Kremer, Samira Caillard, Sophie Kidney Int Letter to the Editor International Society of Nephrology. Published by Elsevier Inc. 2022-11 2022-08-13 /pmc/articles/PMC9375643/ /pubmed/35973595 http://dx.doi.org/10.1016/j.kint.2022.07.022 Text en © 2022 International Society of Nephrology. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Benotmane, Ilies
Velay, Aurélie
Vargas, Gabriela-Gautier
Olagne, Jérôme
Cognard, Noëlle
Heibel, Françoise
Braun-Parvez, Laura
Martzloff, Jonas
Perrin, Peggy
Pszczolinski, Romain
Moulin, Bruno
Fafi-Kremer, Samira
Caillard, Sophie
A rapid decline in the anti–receptor-binding domain of the SARS-CoV-2 spike protein IgG titer in kidney transplant recipients after tixagevimab–cilgavimab administration
title A rapid decline in the anti–receptor-binding domain of the SARS-CoV-2 spike protein IgG titer in kidney transplant recipients after tixagevimab–cilgavimab administration
title_full A rapid decline in the anti–receptor-binding domain of the SARS-CoV-2 spike protein IgG titer in kidney transplant recipients after tixagevimab–cilgavimab administration
title_fullStr A rapid decline in the anti–receptor-binding domain of the SARS-CoV-2 spike protein IgG titer in kidney transplant recipients after tixagevimab–cilgavimab administration
title_full_unstemmed A rapid decline in the anti–receptor-binding domain of the SARS-CoV-2 spike protein IgG titer in kidney transplant recipients after tixagevimab–cilgavimab administration
title_short A rapid decline in the anti–receptor-binding domain of the SARS-CoV-2 spike protein IgG titer in kidney transplant recipients after tixagevimab–cilgavimab administration
title_sort rapid decline in the anti–receptor-binding domain of the sars-cov-2 spike protein igg titer in kidney transplant recipients after tixagevimab–cilgavimab administration
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375643/
https://www.ncbi.nlm.nih.gov/pubmed/35973595
http://dx.doi.org/10.1016/j.kint.2022.07.022
work_keys_str_mv AT benotmaneilies arapiddeclineintheantireceptorbindingdomainofthesarscov2spikeproteiniggtiterinkidneytransplantrecipientsaftertixagevimabcilgavimabadministration
AT velayaurelie arapiddeclineintheantireceptorbindingdomainofthesarscov2spikeproteiniggtiterinkidneytransplantrecipientsaftertixagevimabcilgavimabadministration
AT vargasgabrielagautier arapiddeclineintheantireceptorbindingdomainofthesarscov2spikeproteiniggtiterinkidneytransplantrecipientsaftertixagevimabcilgavimabadministration
AT olagnejerome arapiddeclineintheantireceptorbindingdomainofthesarscov2spikeproteiniggtiterinkidneytransplantrecipientsaftertixagevimabcilgavimabadministration
AT cognardnoelle arapiddeclineintheantireceptorbindingdomainofthesarscov2spikeproteiniggtiterinkidneytransplantrecipientsaftertixagevimabcilgavimabadministration
AT heibelfrancoise arapiddeclineintheantireceptorbindingdomainofthesarscov2spikeproteiniggtiterinkidneytransplantrecipientsaftertixagevimabcilgavimabadministration
AT braunparvezlaura arapiddeclineintheantireceptorbindingdomainofthesarscov2spikeproteiniggtiterinkidneytransplantrecipientsaftertixagevimabcilgavimabadministration
AT martzloffjonas arapiddeclineintheantireceptorbindingdomainofthesarscov2spikeproteiniggtiterinkidneytransplantrecipientsaftertixagevimabcilgavimabadministration
AT perrinpeggy arapiddeclineintheantireceptorbindingdomainofthesarscov2spikeproteiniggtiterinkidneytransplantrecipientsaftertixagevimabcilgavimabadministration
AT pszczolinskiromain arapiddeclineintheantireceptorbindingdomainofthesarscov2spikeproteiniggtiterinkidneytransplantrecipientsaftertixagevimabcilgavimabadministration
AT moulinbruno arapiddeclineintheantireceptorbindingdomainofthesarscov2spikeproteiniggtiterinkidneytransplantrecipientsaftertixagevimabcilgavimabadministration
AT fafikremersamira arapiddeclineintheantireceptorbindingdomainofthesarscov2spikeproteiniggtiterinkidneytransplantrecipientsaftertixagevimabcilgavimabadministration
AT caillardsophie arapiddeclineintheantireceptorbindingdomainofthesarscov2spikeproteiniggtiterinkidneytransplantrecipientsaftertixagevimabcilgavimabadministration
AT benotmaneilies rapiddeclineintheantireceptorbindingdomainofthesarscov2spikeproteiniggtiterinkidneytransplantrecipientsaftertixagevimabcilgavimabadministration
AT velayaurelie rapiddeclineintheantireceptorbindingdomainofthesarscov2spikeproteiniggtiterinkidneytransplantrecipientsaftertixagevimabcilgavimabadministration
AT vargasgabrielagautier rapiddeclineintheantireceptorbindingdomainofthesarscov2spikeproteiniggtiterinkidneytransplantrecipientsaftertixagevimabcilgavimabadministration
AT olagnejerome rapiddeclineintheantireceptorbindingdomainofthesarscov2spikeproteiniggtiterinkidneytransplantrecipientsaftertixagevimabcilgavimabadministration
AT cognardnoelle rapiddeclineintheantireceptorbindingdomainofthesarscov2spikeproteiniggtiterinkidneytransplantrecipientsaftertixagevimabcilgavimabadministration
AT heibelfrancoise rapiddeclineintheantireceptorbindingdomainofthesarscov2spikeproteiniggtiterinkidneytransplantrecipientsaftertixagevimabcilgavimabadministration
AT braunparvezlaura rapiddeclineintheantireceptorbindingdomainofthesarscov2spikeproteiniggtiterinkidneytransplantrecipientsaftertixagevimabcilgavimabadministration
AT martzloffjonas rapiddeclineintheantireceptorbindingdomainofthesarscov2spikeproteiniggtiterinkidneytransplantrecipientsaftertixagevimabcilgavimabadministration
AT perrinpeggy rapiddeclineintheantireceptorbindingdomainofthesarscov2spikeproteiniggtiterinkidneytransplantrecipientsaftertixagevimabcilgavimabadministration
AT pszczolinskiromain rapiddeclineintheantireceptorbindingdomainofthesarscov2spikeproteiniggtiterinkidneytransplantrecipientsaftertixagevimabcilgavimabadministration
AT moulinbruno rapiddeclineintheantireceptorbindingdomainofthesarscov2spikeproteiniggtiterinkidneytransplantrecipientsaftertixagevimabcilgavimabadministration
AT fafikremersamira rapiddeclineintheantireceptorbindingdomainofthesarscov2spikeproteiniggtiterinkidneytransplantrecipientsaftertixagevimabcilgavimabadministration
AT caillardsophie rapiddeclineintheantireceptorbindingdomainofthesarscov2spikeproteiniggtiterinkidneytransplantrecipientsaftertixagevimabcilgavimabadministration